Cannabidiol Treatment for Adult Patients with Drug‐Resistant Epilepsies: A Real‐World Study in a Tertiary Center
Our findings suggest that cannabidiol may benefit all adult patients with DRE, particularly those already receiving clobazam. Randomized controlled trials are warranted in off-label patients to validate these observational findings.
Authors
- S. Dupont (ORCID: https://orcid.org/0000-0003-2080-8253)
- Laurent Bailly (ORCID: https://orcid.org/0000-0002-6565-8212)
- Vincent Navarro (ORCID: https://orcid.org/0000-0003-0077-8114)
- Isabelle Gourfinkel‐An
- Quentin Calonge (ORCID: https://orcid.org/0009-0004-5874-3947)
- Phintip Pichit
- Maria Damiano
- Aurore Besnard
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Sorbonne Université (FR)
- Pitié-Salpêtrière Hospital (FR)
- Institut du Cerveau (FR)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/brb3.70122
- Citations
- 3
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16